Odyssey Health, Inc.
AI Executive Summary
AI-powered analysis of 10-Q filing content
Odyssey Health shows severe financial distress with a $10.6M stockholders' deficit and explosive growth in derivative liabilities to $3.9M. Net losses increased dramatically with massive financing costs of $3.1M over six months, indicating potential toxic financing arrangements. The company's minimal cash position and overwhelming debt burden create material going concern risks.
Red Flags Detected (8)
Stockholders' deficit of $10.6M vs $6.95M deficit in July 2025
Derivative liabilities jumped from $0 to $3.9M in six months
Financing costs of $3.08M in six months vs $0 in prior year
5 more red flags detected
Key Takeaways
Company appears to be in financial distress with no revenue generation
Recent financing appears to involve derivative instruments creating dilution risk
2 more takeaways
Filing Overview
What This Means
Deteriorating Trend: Conditions are worsening compared to previous filings. This may create opportunities for service providers.
Quarterly Report: Interim filing with unaudited financial data for the quarter.